STOCK TITAN

DENTSPLY SIRONA: Vanguard Reports 0% Ownership

DENTSPLY SIRONA Inc ownership update: The Vanguard Group filed an Amendment No. 18 to a Schedule 13G/A reporting 0 shares beneficially owned and 0% of the class.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc ownership update: The Vanguard Group filed an Amendment No. 18 to a Schedule 13G/A reporting 0 shares beneficially owned and 0% of the class. The filing explains an internal realignment at The Vanguard Group that disaggregated certain subsidiaries for separate reporting in reliance on SEC Release No. 34-39538.

The filing is signed by Ashley Grim, Head of Global Fund Administration, and lists Vanguard's registered address in Malvern, Pennsylvania.

Insights

Vanguard reports zero beneficial ownership after internal reporting realignment.

The filing states 0 shares beneficially owned and 0% of the class, reflecting a reporting change tied to an internal realignment and reliance on SEC Release No. 34-39538. This is an administrative disclosure of ownership structure, not an economic transaction.

Relevant items to watch in future filings include any reaggregated disclosures from Vanguard affiliates or subsequent amendments that show holdings; timing or changes are not included in this excerpt.

Disclosure clarifies which Vanguard entities report separately; no change in company control shown here.

The statement explains that subsidiaries or business divisions that formerly reported under The Vanguard Group, Inc. will now report separately, per SEC guidance. The filing attributes the split to an internal realignment effective January 12, 2026.

For investors tracking institutional ownership, subsequent Schedule 13 filings from Vanguard entities may show redistributed holdings; this filing itself only documents reporting allocation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Vanguard's Schedule 13G/A amendment say about DENTSPLY SIRONA (XRAY) ownership?

The amendment reports 0 shares beneficially owned and 0% of the class by The Vanguard Group. It explains an internal realignment that caused certain subsidiaries to report holdings separately, in reliance on SEC Release No. 34-39538.

Why does Vanguard report zero ownership after the January 12, 2026 realignment?

Vanguard states that after an internal realignment on January 12, 2026, certain subsidiaries now report beneficial ownership separately. As a result, The Vanguard Group, Inc. reports 0 shares for this filing, per SEC Release No. 34-39538 guidance.

Who signed the Schedule 13G/A amendment for Vanguard regarding XRAY?

Ashley Grim, Head of Global Fund Administration, signed the amendment dated 03/26/2026. The filing provides Vanguard's principal business address at 100 Vanguard Blvd., Malvern, PA.

Does this filing indicate Vanguard sold all XRAY shares?

No. The filing documents a reporting disaggregation due to internal realignment and states 0 shares for The Vanguard Group; it does not describe sales, purchases, or economic transactions in this excerpt.

Will Vanguard-affiliated entities potentially report XRAY holdings separately?

Yes. The amendment explains certain subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538; subsequent Schedule 13 filings may show holdings under those entities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

Keep reading